Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Acta Neurologica Belgica|February 28, 2007
Pharmacogenetics in neuropsychiatric diseases: epilepsy as a modelC DepondtClinical Neurology and Neurosurgery|March 30, 2010
Acute behavioural change in a young woman evolving towards cerebellar syndromeG Naeije, Q de Hemptinne, C Depondt, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 10, 2019
Epileptic activity in neurological deterioration after ischemic stroke, a continuous EEG studyP Scoppettuolo, N Gaspard, C Depondt, et al.European Journal of Neurology|February 23, 2011
A candidate gene study of antiepileptic drug tolerability and efficacy identifies an association of CYP2C9 variants with phenytoin toxicityC Depondt, P Godard, R S Espel, et al.Neurology|May 16, 2002
Familial temporal lobe epilepsy with febrile seizuresC Depondt, W Van Paesschen, G Matthijs, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 5, 2020
Validation of an algorithm of time-dependent electro-clinical risk stratification for electrographic seizures (TERSE) in critically ill patientsF A Cissé, G M Osman, B Legros, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2005
The long term retention of levetiracetam in a large cohort of patients with epilepsyC Depondt, A W C Yuen, G S Bell, et al.Neurology|October 27, 2004
The -1021C->T DBH gene variant is not associated with epilepsy or antiepileptic drug responseC Depondt, H R Cock, D G Healy, et al.Acta Neurologica Belgica|November 10, 2006
Guidelines for the management of epilepsy in the elderlyM Ossemann, E Bruls, V de Borchgrave, et al.Epilepsy Research|November 4, 2008
No major role of common SV2A variation for predisposition or levetiracetam response in epilepsyJ M Lynch, S K Tate, P Kinirons, et al.Pageof 2